Oxford Nanopore Technologies has teamed up with Cepheid to speed up infectious disease genomic analysis, blocking out recent ...

Oxford Nanopore Technologies, which develops and sells nanopore sequencing products, has announced the expansion of its Compatible Products Programme. These products are used for DNA or RNA sequencing ...

Oxford Nanopore Technologies PLC ( ($GB:ONT) ) just unveiled an update. Oxford Nanopore Technologies PLC announced a transaction involving its ...

Oxford Nanopore Technologies (LON:ONT – Free Report) had its price objective reduced by Berenberg Bank from GBX 282 ($3.64) to GBX 250 ($3.23) in a report issued on Wednesday, MarketBeat reports.

April 9, 2025 /PRNewswire/ -- Oxford Nanopore Technologies, the company behind a new generation of sequencing-based molecular analysis technologies, and Cepheid, a leading molecular diagnostics ...

The FTSE 250 can be overlooked by investors, but analysts believe this stock in particular could be undervalued by as much as 69%. Dr James Fox explores. The post 1 FTSE 250 stock that analysts are ...

ONT will report FY 2025 earnings on 03/24/2026 Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are ...

Oxford Nanopore Technologies has teamed up with Cepheid to speed up infectious disease genomic analysis, blocking out recent noise of acquisition vulnerability. The UK biotech, a former star of ...

CEO of Oxford Nanopore Technologies. "By partnering to integrate our richer data, rapid insights, and accessible and affordable sequencing technology with Cepheid's GeneXpert architecture ...